Test Price
2,800 AEDโ Home Collection Available
BMPR1B Gene Brachydactyly Type A2 Genetic Test in Dubai | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Complimentary post-test telephonic consultation by a DHA-licensed Consultant Medical Genetics.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The BMPR1B NGS test analyzes the full coding region of the BMPR1B gene using next-generation sequencing to confirm a molecular diagnosis of Brachydactyly Type A2, a rare autosomal dominant skeletal dysplasia. This assay provides definitive variant detection for clinical management, genetic counseling, and family planning.
| Feature | Our Test (NGS) | Sanger Sequencing (Alternative) |
|---|---|---|
| Gene Coverage | Full coding & splice sites | Known familial mutations only |
| Variant Types Detected | SNVs, indels, CNVs | Single nucleotide variants |
| Sensitivity | >99.9% | ~95% for targeted regions |
| Turnaround Time | 3โ4 weeks | 2โ3 weeks |
| Price (AED) | 2,800 | 1,800โ3,000 |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics practicing within Dubai Healthcare City, I emphasize that the BMPR1B sequencing assay provides robust molecular confirmation of Brachydactyly Type A2. However, genomic data must always be interpreted within the full clinical context, including radiographic findings and family pedigree. A negative result does not exclude other skeletal dysplasias; multidisciplinary evaluation remains the cornerstone of care.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory & Medication Protocol
Do not discontinue or modify any prescribed medication or therapy without direct consultation with your treating physician. Genetic predisposition results do not override acute clinical management strategies. Results should be integrated into a comprehensive care plan by a qualified clinical geneticist.
Safety Exclusion Criteria & Urgent Care Red Flags
- Not indicated for isolated cosmetic concerns unrelated to clinical or radiographic features of Brachydactyly Type A2.
- If the patient has received a bone marrow transplant or has active hematologic malignancy, extracted DNA from an alternative tissue source (e.g., skin biopsy) may be required for accurate germline analysis.
- Seek immediate medical attention for acute hand pain, sudden joint deformity, signs of systemic infection, or respiratory difficultyโthese symptoms require urgent evaluation and are independent of genetic testing.
- Informed consent from a legal guardian is mandatory for minors prior to sample collection, accompanied by mandatory genetic counseling as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the BMPR1B gene test detect and why is it needed?
This test detects pathogenic variants in the BMPR1B gene causing Brachydactyly Type A2 to confirm diagnosis and guide family planning. It is indicated for individuals with shortened fingers or toes (brachydactyly), especially when type A2 is suspected based on clinical and radiographic findings, or when a family history suggests autosomal dominant inheritance. Results enable precise genetic counseling and reproductive options.
2. How is the sample collected and how long do results take?
A simple blood draw or dried blood spot on an FTA card is collected at home by our mobile phlebotomist, with results available in 3โ4 weeks. Our VIP home collection service follows hospital-grade cold-chain protocols, ensuring sample stability. You will receive a secure electronic report, and a DHA-licensed Consultant Medical Genetics can provide interpretation within 48 hours of report delivery.
3. Is this covered by UAE health insurance?
Yes, we offer direct billing verification with major UAE insurers; simply message +971 54 548 8731 on WhatsApp for confirmation. Our billing team will check your policy coverage for genetic testing based on DHA guidelines. Many premium plans cover NGS-based tests when preauthorized by a pediatrician or clinical geneticist.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA-licensed diagnostic facility (License No: 1143). We strictly adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genomic data is encrypted, access-controlled, and processed exclusively within the UAE jurisdiction.
All clinical procedures and sampling protocols comply with the ethical and safety standards of Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | BMPR1B Gene Brachydactyly Type A2 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full Coding Region & Splice Sites |
| ICD-10-CM Code | Q73.8 |
| LOINC Code | 21635-7 |
| DHA Facility License & Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians